OncoMed Pharmaceuticals, Inc.
     
 
 

Management

Paul J. Hastings
Chairman and Chief Executive Officer
John Lewicki, Ph.D.
Executive Vice President, Research and Development
Austin Gurney, Ph.D.
Senior Vice President, Molecular and Cellular Biology and co-Chief Scientific Officer
Tim Hoey, Ph.D.
Senior Vice President, Cancer Biology and co-Chief Scientific Officer
Sunil Patel
Chief Financial Officer, Senior Vice President, Corporate Development and Finance
Alicia J. Hager, J.D., Ph.D.
Senior Vice President and General Counsel
Robert Stagg, Pharm.D.
Senior Vice President, Clinical Research and Development
Leonardo Faoro, MD, MBA
Vice President, Clinical Development
Jill Henrich
Vice President, Regulatory Affairs
Ann Kapoun, Ph.D.
Vice President, Translational Medicine
Stock Quote (NASDAQ: OMED)
Price:
3.94
Change:
- 0.06
Day High:
4.05
Day Low:
3.87
Volume:
259,157
4:00 PM ET on Apr 28, 2017
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations